EZDebride clinical trial results at AAHCM Annual Meeting
Thomas E. Serena M.D. F.A.C.S., founder and medical director of the SerenaGroup family of advanced wound and hyperbaric centers, will present at this fall’s American Academy of Home Care Medicine (AAHCM) virtual meeting (Friday, October 23, 2020). The presentation will center on the results of a recently completed clinical trial on the use of EZDebride in chronic wounds. The study examined the effectiveness of EZDebride in the post-acute setting. In addition, it evaluated the ability of EZDebride to reduce bacterial burden using the MolecuLight procedure (MLiX).
